Applications Published 27 September 2000

Published: 25-Apr-2001

The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).


The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).

  • Human tumour necrosis factor-R2-like proteins
    Incyte Pharmaceuticals 1037908*

  • Maintenance of smooth-muscle integrity of morphogenic proteins
    Creative Biomolecules 1037910*

  • Anti-pathogen system and methods of uses thereof
    Washington University 1037911*

  • DNA molecules encoding vertebrate nuclear receptor protein, NNR4
    Merck 1037912*

  • Galanin receptor GALR3 and nucleotides encoding same
    Merck 1037913*

  • Mammalian calcitonin-like polypeptide-1
    ZymoGenetics 1037914*

  • Matrix-remodelling genes
    Incyte Pharmaceuticals 1037915*

  • Erythrovirus and its applications
    Assistance Publique 1037916*

  • Recombinant nodavirus compsns and methods
    Pentamer Pharmaceuticals 1037917*

  • Method and compsn to enhance the efficacy of a vaccine using chemokines
    University of Maryland Biotechnology Institute 1037918*

  • Proteins for cancer cell specific induction of apoptosis and method for isolation thereof
    Tsai, David; Yu, Jenny 1037919*

  • Erythropoietin with high specific activity
    Roche Diagnostics 1037921*

  • Flexible gelatin free encapsulation material useful for pharmaceuticals, paint balls and other formulations
    Rheox 1038521

  • Anticonvulsant enantiomeric amino acid derivatives
    Research Corporation Technologies 1038522

  • Method for identifying compounds for inhibition of neoplastic legions
    Cell Pathways 1038523

  • L-threonate ferrous, as well as pharmaceutical compsn and use for improving and reating human anaemia thereof
    Beijing Juneng Asia-Pacific Lite Scientific Research Centre 1038524

  • Stable drug compsn
    Dainippon Pharmaceutical 1038525

  • Treatment fo functional disorders of the lower intestinal tract and subsequent visceral pain with moxonidine
    Solvay Pharmaceuticals 1038526

  • Process for producing granulates containing riboflavine
    BASF 1038527

  • Pentosan polysulphate containing medicament and implant for treating fibrosis
    Gliatech 1038528

  • Agent for increasing chemokine production
    Nippon Zoli Pharmaceutical 1038529
  • You may also like